Watton Corey Michael - Net Worth and Insider Trading
Watton Corey Michael Net Worth
The estimated net worth of Watton Corey Michael is at least $4,650 dollars as of 2024-06-09. Watton Corey Michael is the Director of Zevra Therapeutics Inc and owns about 1,000 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $4,650. Details can be seen in Watton Corey Michael's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Watton Corey Michael has not made any transactions after 2023-06-23 and currently still holds the listed stock(s).
Transaction Summary of Watton Corey Michael
Watton Corey Michael Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Watton Corey Michael owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Watton Corey Michael’s form 4 insider trades.
Insider Ownership Summary of Watton Corey Michael
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-06-23 | director |
Watton Corey Michael Latest Holdings Summary
Watton Corey Michael currently owns a total of 1 stock. Watton Corey Michael owns 1,000 shares of Zevra Therapeutics Inc (ZVRA) as of June 23, 2023, with a value of $4,650.
Latest Holdings of Watton Corey Michael
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-06-23 | 1,000 | 4.65 | 4,650 |
Holding Weightings of Watton Corey Michael
Watton Corey Michael Form 4 Trading Tracker
According to the SEC Form 4 filings, Watton Corey Michael has made a total of 3 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 275 shares on June 23, 2023, which cost Watton Corey Michael around $1,636.
Insider Trading History of Watton Corey Michael
- 1
Watton Corey Michael Trading Performance
GuruFocus tracks the stock performance after each of Watton Corey Michael's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Watton Corey Michael is -4.03%. GuruFocus also compares Watton Corey Michael's trading performance to market benchmark return within the same time period. The performance of stocks bought by Watton Corey Michael within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Watton Corey Michael's insider trading performs compared to the benchmark.
Performance of Watton Corey Michael
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.58 | | | | | |
| Relative Return to S&P 500(%) | -11.74 | | | | | |
Watton Corey Michael Ownership Network
Watton Corey Michael Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Watton Corey Michael is the director of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , VP Fin & Corp Controller R. Laduane Clifton , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Watton Corey Michael made 3 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 1,000. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 6,100 shares made by R. Laduane Clifton , a net purchase of 3,500 shares made by Joshua Schafer , and a net purchase of 20,000 shares made by John B Bode .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 77,819 shares were bought by its insiders, resulting in a net purchase of 77,819 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Watton Corey Michael Mailing Address
Above is the net worth, insider trading, and ownership report for Watton Corey Michael. You might contact Watton Corey Michael via mailing address: 22045 Karen Street, Elkhorn Ne 68022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
